MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$7,964,000
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenues
0
0
0
0
Research and development
5,450,000
5,378,000
5,118,000
3,738,000
General and administrative
2,103,000
2,488,000
2,407,000
2,147,000
Depreciation and amortization
8,000
8,000
9,000
21,000
Total operating expenses
7,561,000
7,874,000
7,534,000
5,906,000
Loss from operations
-7,561,000
-7,874,000
-7,534,000
-5,906,000
Gain (loss) from change in fair value of warrant liability
7,000
-10,770,000
-4,187,000
-1,591,000
Transaction costs allocated to warrant liabilities
2,000
693,000
-2,118,000
530,000
Loss on extinguishment of warrant liabilities
-
-
-614,000
-
Gain on issuance of warrant liabilities
0
-15,158,000
7,797,000
-20,609,000
Other income, net
13,000
76,000
-49,000
16,000
Interest income (expense), net
-78,000
34,000
10,000
39,000
Net gain
-7,635,000
-12,845,000
5,915,000
-25,399,000
Foreign currency translation
-
-
-
-6,000
Warrant deemed dividend
329,000
1,765,000
101,000
-
Comprehensive loss
-
-
-
-25,405,000
Net loss available to common stockholders
-7,964,000
-14,610,000
5,814,000
-
Basic EPS
-1.4
-3.54
4.908
-0.68
Basic Average Shares
5,680,717
4,124,482
1,184,569*
37,304,455
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss available
to common...
-$7,964,000
Net gain
-$7,635,000
(0.07%↑ Y/Y)
Warrant deemed dividend
$329,000
Other income, net
$13,000
(225.00%↑ Y/Y)
Loss from operations
-$7,561,000
(-32.19%↓ Y/Y)
Interest income
(expense), net
-$78,000
(-400.00%↓ Y/Y)
Gain (loss) from
change in fair value of...
$7,000
(100.07%↑ Y/Y)
Transaction costs allocated
to warrant...
$2,000
(-99.83%↓ Y/Y)
Total operating
expenses
$7,561,000
(32.19%↑ Y/Y)
Research and development
$5,450,000
(51.39%↑ Y/Y)
General and
administrative
$2,103,000
(0.57%↑ Y/Y)
Depreciation and
amortization
$8,000
(-72.41%↓ Y/Y)
Buy us a coffee
Moleculin Biotech, Inc. (MBRX)
Moleculin Biotech, Inc. (MBRX)